z-logo
open-access-imgOpen Access
Clinical efficacy and safety of high-dose imatinib for chronic myeloid leukemia patients: An updated meta-analysis
Author(s) -
Yonghua Liu,
Bingmu Fang,
Jinhong Jiang,
Peng Wang
Publication year - 2016
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.191623
Subject(s) - imatinib , myeloid leukemia , medicine , meta analysis , oncology , leukemia
The aim of this study was to evaluate the clinical efficacy and safety of high-dose imatinib (IM) for chronic myeloid leukemia (CML) patients by pooled published studies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here